In Brief: Summit Technology
This article was originally published in The Gray Sheet
Executive Summary
Summit Technology: Summary of safety and effectiveness data for Summit's SVS Apex excimer laser PMA is available through FDA's Dockets Management Branch, according to an Aug. 15 Federal Register notice. A premarket approval application for the laser's use in photorefractive keratectomy received FDA approval Oct. 20, 1995. Publication of the summary allows for submission of petitions challenging the approval. FDA has said it expects the Summit PMA, as well as Visx's PMA for its Star PRK laser to be challenged. For more information, contact Debra Lewis, head of the Center for Devices and Radiological Health's Staff College, at 301/827-3623...
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.